|
Index of reports
> Cases resulting in a serious event (101)
> Cases with Pregnancy (9)
Below is the selection of adverse event reports related to Zerit (Stavudine) that includes cases resulting in a serious event where reactions include pregnancy.
Adverse event in female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-08
Patient: female
Adverse reactions / side effects: Cerebral Disorder, Rhinitis, Neutropenia, Foetal Growth Retardation, Pregnancy, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Crixivan
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Epivir
Dosage: exposure began in week 29 of gestation.
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Fortovase
Dosage: exposure began in week 29 of gestation.
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Lamivudine
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Retrovir
Dosage: exposure began in week ten of gestation.
Indication: HIV Test Positive
Start date: 1997-07-01
End date: 1998-01-19
Videx
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Zerit
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Zidovudine
Indication: HIV Infection
Start date: 1997-01-01
End date: 1997-01-01
Zidovudine
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Adverse event in female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-30
Patient: female, weighing 1.0 kg (2.2 pounds)
Adverse reactions / side effects: Ileostomy, Premature Baby, Alanine Aminotransferase Increased, Thrombocythaemia, Necrotising Colitis, Speech Disorder, Colectomy Total, Blood Creatinine Increased, Enterocolitis, Pregnancy
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Invirase
Dosage: exposure during gestation.
Norvir
Dosage: exposure during gestation.
Retrovir
Dosage: exposure during delivery.
Start date: 1999-07-02
End date: 1999-07-02
Retrovir
Dosage: initiated at 8 mg/kg/day, 6 mg/kg/day from 7/6/99, then 1.4 mg/kg twice daily from 7/11/99.
Indication: Prophylaxis
Start date: 1999-07-02
End date: 1999-08-10
Retrovir
Administration route: Oral
Start date: 1999-07-07
End date: 1999-07-18
Videx
Dosage: exposure during gestation.
Zerit
Dosage: exposure during gestation.
Other drugs received by patient: Bactrim; Triflucan; Loxen; Celestene; Salbutamol
Adverse event in female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-30
Patient: female
Adverse reactions / side effects: Cerebral Disorder, Rhinitis, Neutropenia, Foetal Growth Retardation, Pregnancy, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Crixivan
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Epivir
Dosage: exposure began in week 29 of gestation.
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Fortovase
Dosage: exposure began in week 29 of gestation.
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Lamivudine
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Retrovir
Dosage: exposure began in week ten of gestation.
Indication: HIV Test Positive
Start date: 1997-07-01
End date: 1998-01-19
Videx
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Zerit
Dosage: exposure began in week two of gestation.
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Zidovudine
Indication: HIV Infection
Start date: 1997-01-01
End date: 1997-01-01
Zidovudine
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Adverse event in 33 year old female receiving Zerit (Stavudine)
Reported by a consumer/non-health professional from Japan on 2007-05-29
Patient: 33 year old female
Adverse reactions / side effects: Normal Newborn, Musculoskeletal Pain, Anaemia, Blood Triglycerides Increased, Pregnancy, Deep Vein Thrombosis
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-03
Viracept
Dosage: viracept (nfv) 2200-2500 mg/day dosed
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-10
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-03
Other drugs received by patient: Retrovir
Adverse event in 28 month old female receiving Zerit (Stavudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-29
Patient: 28 month old female
Adverse reactions / side effects: Electroencephalogram Abnormal, Drug Exposure During Pregnancy, Nervous System Disorder, Nuclear Magnetic Resonance Imaging Abnormal, Pregnancy
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: from the 17th week of gestation to the 26th week.
Start date: 1997-11-01
End date: 1998-04-01
Epivir
Dosage: syrup
Administration route: Oral
Start date: 1997-11-01
End date: 1998-01-01
Invirase
Dosage: from the 17th week to the end of pregnancy.
Start date: 1997-11-01
End date: 1998-04-01
Norvir
Dosage: from the 17th week to the end of pregnancy.
Start date: 1997-11-01
End date: 1998-04-01
Retrovir
Dosage: from the 13th week to the 26th week of gestation.
Start date: 1997-10-01
End date: 1998-01-01
Retrovir
Dosage: syrup
Administration route: Oral
Start date: 1997-10-01
End date: 1998-01-01
Videx
Dosage: from the 26th week of gestation.
Start date: 1998-01-14
Zerit
Dosage: from the 26th week of gestation.
Start date: 1998-01-14
Adverse event in 33 year old female receiving Zerit (Stavudine)
Reported by a consumer/non-health professional from Japan on 2007-05-01
Patient: 33 year old female
Adverse reactions / side effects: Anaemia, Musculoskeletal Pain, Blood Triglycerides Increased, Pregnancy, Deep Vein Thrombosis, Infant
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-03
Viracept
Dosage: viracept (nfv) 2200-2500 mg/day dosed
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-10
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-03
Adverse event in male receiving Zerit (Stavudine)
Reported by a physician from United States on 2007-02-15
Patient: male
Adverse reactions / side effects: Nose Deformity, Premature Baby, Talipes, Lower Limb Deformity, Pregnancy
Adverse event resulted in: disablity
Suspect drug(s):
Efavirenz
Indication: HIV Infection
Start date: 2005-02-23
End date: 2005-12-29
Epivir
Start date: 2005-02-23
Retrovir
Start date: 2005-12-29
Viramune
Start date: 2005-12-29
Zerit
Start date: 2005-02-23
End date: 2005-12-29
Other drugs received by patient: Bactrim; Vitamin B Complex CAP
Adverse event in male receiving Zerit (Stavudine)
Reported by a physician from United States on 2007-02-09
Patient: male
Adverse reactions / side effects: Nose Deformity, Premature Baby, Talipes, Lower Limb Deformity, Pregnancy
Adverse event resulted in: disablity
Suspect drug(s):
Efavirenz
Indication: HIV Infection
Start date: 2005-02-23
End date: 2005-12-29
Epivir
Start date: 2005-02-23
Retrovir
Start date: 2005-12-29
Viramune
Start date: 2005-12-29
Zerit
Start date: 2005-02-23
End date: 2005-12-29
Other drugs received by patient: Bactrim; Vitamin B Complex CAP
Adverse event in female receiving Zerit (Stavudine)
Reported by a consumer/non-health professional from United States on 2007-01-12
Patient: female
Adverse reactions / side effects: Anaemia, Thrombocythaemia, Pregnancy, Blood Lactic Acid Increased, Hypertriglyceridaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Administration route: Oral
Start date: 1999-02-19
Retrovir
Indication: HIV Test Positive
Start date: 1999-02-19
Viracept
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-19
Zerit
Administration route: Oral
Start date: 1999-02-19
Other drugs received by patient: Methadone HCL
|
